HomeINM • NASDAQ
add
InMed Pharmaceuticals Inc
Previous close
$2.08
Day range
$2.07 - $2.22
Year range
$1.72 - $8.27
Market cap
5.01M USD
Avg Volume
111.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.30M | 1.69% |
Operating expense | 2.42M | -2.27% |
Net income | -1.79M | 7.71% |
Net profit margin | -137.07 | 9.24% |
Earnings per share | — | — |
EBITDA | -1.79M | 8.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.12M | 68.10% |
Total assets | 15.58M | 31.78% |
Total liabilities | 2.15M | -18.00% |
Total equity | 13.43M | — |
Shares outstanding | 2.38M | — |
Price to book | 0.31 | — |
Return on assets | -37.05% | — |
Return on capital | -41.78% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.79M | 7.71% |
Cash from operations | -1.78M | -72.81% |
Cash from investing | 0.00 | — |
Cash from financing | 8.17M | 4,644,531.25% |
Net change in cash | 6.40M | 721.59% |
Free cash flow | -1.06M | -325.17% |
About
Founded
1981
Headquarters
Website
Employees
13
